A comparison of five paediatric dosing guidelines for antibiotics
(c) 2020 The authors; licensee World Health Organization..
OBJECTIVE: To compare dosing guidance in the paediatric formularies of high- and middle-income countries for 32 commonly prescribed antibiotics on the World Health Organization's (WHO's) 2017 Model list of essential medicines for children.
METHODS: We identified paediatric antibiotic guidelines that were either widely used internationally or originated from countries in which antibiotic use has increased markedly in recent years (i.e. Brazil, China, India, the Russian Federation and South Africa).
FINDINGS: The study analysis considered five leading antibiotic guidelines: (i) the Manual of childhood infections: the blue book; (ii) the BNF (British national formulary) for children; (iii) the Red book®: 2018-2021 report of the committee on infectious diseases; (iv) WHO's Pocket book of hospital care for children; and (v) Indian National treatment guidelines for antimicrobial use in infectious diseases. There was marked heterogeneity in the recommended dosing (i.e. daily dose, age dosing bands and dose frequency) for most commonly used antibiotics. The rationale for dosing recommendations was generally unclear.
CONCLUSION: The pharmacokinetic, pharmacodynamic and clinical evidence supporting paediatric antibiotic dosing, particularly on total doses and on age or weight dosing bands, needs to be improved. Future research should consider whether the variations in guidance identified stem from different clinical disease patterns, varying levels of antibiotic resistance or drug availability rather than historical preferences. Interested global parties could collaborate with WHO's Model list of essential medicines antibiotic working group to develop an evidence-based consensus and identify research priorities.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:98 |
|---|---|
| Enthalten in: |
Bulletin of the World Health Organization - 98(2020), 6 vom: 01. Juni, Seite 406-412F |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mathur, Shrey [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 30.06.2020 Date Revised 14.04.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.2471/BLT.19.234310 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM310936640 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM310936640 | ||
| 003 | DE-627 | ||
| 005 | 20231225141153.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2471/BLT.19.234310 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1036.xml |
| 035 | |a (DE-627)NLM310936640 | ||
| 035 | |a (NLM)32514214 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mathur, Shrey |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A comparison of five paediatric dosing guidelines for antibiotics |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.06.2020 | ||
| 500 | |a Date Revised 14.04.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a (c) 2020 The authors; licensee World Health Organization. | ||
| 520 | |a OBJECTIVE: To compare dosing guidance in the paediatric formularies of high- and middle-income countries for 32 commonly prescribed antibiotics on the World Health Organization's (WHO's) 2017 Model list of essential medicines for children | ||
| 520 | |a METHODS: We identified paediatric antibiotic guidelines that were either widely used internationally or originated from countries in which antibiotic use has increased markedly in recent years (i.e. Brazil, China, India, the Russian Federation and South Africa) | ||
| 520 | |a FINDINGS: The study analysis considered five leading antibiotic guidelines: (i) the Manual of childhood infections: the blue book; (ii) the BNF (British national formulary) for children; (iii) the Red book®: 2018-2021 report of the committee on infectious diseases; (iv) WHO's Pocket book of hospital care for children; and (v) Indian National treatment guidelines for antimicrobial use in infectious diseases. There was marked heterogeneity in the recommended dosing (i.e. daily dose, age dosing bands and dose frequency) for most commonly used antibiotics. The rationale for dosing recommendations was generally unclear | ||
| 520 | |a CONCLUSION: The pharmacokinetic, pharmacodynamic and clinical evidence supporting paediatric antibiotic dosing, particularly on total doses and on age or weight dosing bands, needs to be improved. Future research should consider whether the variations in guidance identified stem from different clinical disease patterns, varying levels of antibiotic resistance or drug availability rather than historical preferences. Interested global parties could collaborate with WHO's Model list of essential medicines antibiotic working group to develop an evidence-based consensus and identify research priorities | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 700 | 1 | |a Jackson, Charlotte |e verfasserin |4 aut | |
| 700 | 1 | |a Urus, Heather |e verfasserin |4 aut | |
| 700 | 1 | |a Ziarko, Isabelle |e verfasserin |4 aut | |
| 700 | 1 | |a Goodbun, Matt |e verfasserin |4 aut | |
| 700 | 1 | |a Hsia, Yingfen |e verfasserin |4 aut | |
| 700 | 1 | |a Ellis, Sally |e verfasserin |4 aut | |
| 700 | 1 | |a Sharland, Mike |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bulletin of the World Health Organization |d 1948 |g 98(2020), 6 vom: 01. Juni, Seite 406-412F |w (DE-627)NLM000211265 |x 1564-0604 |7 nnns |
| 773 | 1 | 8 | |g volume:98 |g year:2020 |g number:6 |g day:01 |g month:06 |g pages:406-412F |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2471/BLT.19.234310 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 98 |j 2020 |e 6 |b 01 |c 06 |h 406-412F | ||